Key Points Humacyte’s interim Phase 3 V012 results were accepted for a late-breaking oral presentation at ASN Kidney Week 2026. The randomized trial compares its…
AstraZeneca attributes its Phase 3 HICKORY miss in hypophosphatasia to trial design, as Mereo seeks a path forward with the FDA and Mirum wins approval…
World Mental Health Day 2026: Why Lived Experience Now Moves Markets This Saturday, October 10, marks World Mental Health Day. The World Federation for Mental…
Key Points Sagimet is presenting long-term results for its experimental acne pill, denifanstat, at a dermatology conference in Las Vegas. A study in China reported…
Myriad Genetics Advances Prostate Cancer Biomarker Through SOPHiA GENETICS Collaboration
Key Points Myriad Genetics is partnering with SOPHiA GENETICS to advance its prostate cancer-specific genomic instability score, or PrGIS, in precision oncology work involving AstraZeneca….
Key Points Preliminary third-quarter 2026 revenue is expected to reach $9.8 million to $10.0 million, representing a quarterly record. Revenue is expected to rise approximately…
Rett Syndrome Awareness Month: Acadia Extends Drug Protection as Taysha Gene Therapy Nears Pivotal Data
Acadia has the first approved Rett syndrome treatment and a path to five more years of U.S. exclusivity. Taysha has finished dosing a pivotal trial…
Key Points BioLineRx and Hemispherian will present two GLIX1 posters at the Society for Neuro-Oncology annual meeting in Philadelphia. Both presentations are scheduled for November…
Perspective Therapeutics Wins FDA Fast Track Status for Targeted Therapy in Rare Tumors
Key Points The FDA granted Fast Track designation to PSV359 for adults with FAP-positive solitary fibrous tumors that are locally advanced and unresectable and/or metastatic….
Key Points Armata announced two issued U.S. patents covering treatment methods involving its investigational bacteriophage candidates, AP-SA02 and AP-PA02. The AP-SA02 patent was issued October…
Key Points Owlet launched a partnership with VillageFor to support new and expecting parents through pregnancy, postpartum and other paths to parenthood. Owlet360 members will…
Key Points Neogen’s fiscal first-quarter revenue rose 6.5% to $222.8 million, with core growth of 8.1%. Adjusted EBITDA increased 17% to $41.6 million, and adjusted…





